Aeterna Zentaris to Present at Upcoming Canaccord Genuity 30th Annual Growth Conference in Boston

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUBEC CITY, Aug. 2, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX:AEZ) (the \"Company\") today announced that its Senior Vice\n President and Chief Medical Officer, Paul Blake, MD, will make a\n corporate presentation at the upcoming Canaccord Genuity 30th Annual Growth Conference on Tuesday, August 9, 2011, at 2 p.m. (Eastern\n Time) in the London Room of the Intercontinental Boston Hotel, in\n Boston.\n\n\nA live webcast of the presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of \"personalized\n medicine\" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com.\n\n\n","length":1456,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.